id: sphingolipid_metabolism_alteration_to_myocardial_infarction_protection
name: Sphingolipid Metabolism Alteration → Myocardial Infarction Protection
from_node:
  node_id: sphingolipid_metabolism_alteration
  node_name: Sphingolipid Metabolism Alteration
to_node:
  node_id: myocardial_infarction_protection
  node_name: Myocardial Infarction Protection
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: Therapeutic or physiological alterations in sphingolipid metabolism modify
  the enzymatic transformation pathways of sphingosine-derived compounds'
- 'Step 2: Modified sphingolipid signaling affects cellular pathways controlling proliferation,
  maturation, and death in cardiac tissue'
- 'Step 3: These altered signaling cascades provide cardioprotective effects against
  ischemic injury during myocardial infarction events'
evidence:
  quality_rating: C
  n_studies: null
  primary_citation: S. Borodzicz-Jażdżyk et al. 2022. "Sphingolipid metabolism and
    signaling in cardiovascular diseases." *Frontiers in Cardiovascular Medicine*.
    https://doi.org/10.3389/fcvm.2022.915961
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.445189'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/sphingolipid_metabolism_alteration_to_myocardial_infarction_protection.yaml
_category: biological
